<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01967121</url>
  </required_header>
  <id_info>
    <org_study_id>IRB# 13-849F</org_study_id>
    <nct_id>NCT01967121</nct_id>
  </id_info>
  <brief_title>Compex Use With Delayed Onset Muscle Soreness: A Comparison to Other Methods</brief_title>
  <official_title>Compex Use With Delayed Onset Muscle Soreness: A Comparison to Other Methods</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michigan State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Michigan State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to determine if the application of ice, control group,
      or a muscle stimulation program from the Compex® series can help reduce or eliminate delayed
      muscle soreness from performing leg extension and flexion. Individuals will complete a health
      history questionnaire to determine if they qualify for this study. We will measure your leg
      girth with a measuring tape and take a pain measurement of your hamstrings by using a spring
      to press down on your leg. Individuals will then warm-up on a bike without resistance for 5
      minutes followed by 10 regular leg extension and flexion exercises. Individuals will then
      perform 6 sets of 10 leg extension and flexion exercises on a biodex machine (similar to leg
      curl machines in the gym). Individuals will perform each set to the maximum effort of their
      capables. After each set of 10 individuals will have a 2 minute rest. We will ask you to rank
      your leg soreness on a scale from 1-10.

      Individuals will then be assigned to a modality of either ice, control group or compex.
      Individuals will perform the modality (ice, control, compex) we assign you to until you are
      no longer sore.

      Over the next five days individuals will return to measure their level of soreness, leg girth
      and pain pressure.

      This study will examine the following hypotheses:

      H1: There will be no difference in pressure pain threshold after using the Compex compared to
      other groups.

      H2: There will be no difference in perceived soreness after using the Compex compared to
      other groups.

      H3: There will be no difference in muscular strength after using the Compex compared to other
      groups.

      H4: There will be no difference in active range of motion after using the Compex compared to
      other groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Scores on the Visual Analog Scale</measure>
    <time_frame>Day 1 through Day 5</time_frame>
    <description>Visual Analog Scale for Muscle Soreness scale The scale for measuring the intensity of muscle soreness will be a 10 cm visual analog scale, spaced by one centimeter increments from one to 10. Ten will represent the maximum amount of soreness and zero represents no soreness at all. Subjects will be asked to complete this scale once per day at the same time of day until the soreness has dissipated. The Visual Analog Scale for muscle soreness is measured as 'scores on a scale'.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Focus of Study is to Determine Efficacy of Compex</condition>
  <arm_group>
    <arm_group_label>'Compex unit's Active Recovery® program'</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Compex electrical stimulation system utilized in this study is intended for external application with electrodes to create a muscular contraction and help enhance recovery after eccentric muscular activity.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ice application</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A randomized pre and post-test research design will be used to compare three interventions (control, ice, compex) to alleviate the physical symptoms of delayed-onset muscle soreness (DOMS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This is a control group where subjects will not perform an intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Compex unit's Active Recovery® program</intervention_name>
    <description>Compex unit's Active Recovery® program will be performed for 15 minutes once per day.</description>
    <arm_group_label>'Compex unit's Active Recovery® program'</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ice application</intervention_name>
    <description>Participants will apply ice on their hamstring for 15 minutes three times per day until muscle soreness is no longer present</description>
    <arm_group_label>Ice application</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The studied population will be composed of 45 physically active college students
             between the ages of 18-30 years old.

          -  Inclusionary criteria will be participation in a physical activity as defined by the
             ACSM, which can be a mixture of moderate (i.e., sufficient to raise the heart rate and
             begin to sweat) and vigorous (i.e., breathing hard and fast with a rapidly rising
             heart rate) intensity aerobic activity and muscle strengthening (i.e., weights lifted
             to the point where anther repetition cannot be completed without help) activities two
             or more time per week (ACSM, 2011.)

        Exclusion Criteria:

          -  Exclusionary criteria will be surgery within the last six months requiring
             immobilization for more than four weeks, discomfort performing intense physical
             activity, diseases like muscular dystrophy that predispose muscular damage beyond
             reasonable levels resulting from physical activity, and current injury of the knees or
             hips.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tracey Covassin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Michigan State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Michigan State University</name>
      <address>
        <city>East Lansing</city>
        <state>Michigan</state>
        <zip>48824</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2013</study_first_submitted>
  <study_first_submitted_qc>October 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2013</study_first_posted>
  <results_first_submitted>April 23, 2014</results_first_submitted>
  <results_first_submitted_qc>August 28, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 29, 2014</results_first_posted>
  <last_update_submitted>August 28, 2014</last_update_submitted>
  <last_update_submitted_qc>August 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Michigan State University</investigator_affiliation>
    <investigator_full_name>Tracey Covassin</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Compex, ice</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myalgia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>'Compex Unit's Active Recovery® Program'</title>
          <description>The Compex electrical stimulation system utilized in this study is intended for external application with electrodes to create a muscular contraction and help enhance recovery after eccentric muscular activity.
Compex unit's Active Recovery® program: Compex unit's Active Recovery® program will be performed for 15 minutes once per day.</description>
        </group>
        <group group_id="P2">
          <title>Ice Application</title>
          <description>A randomized pre and post-test research design will be used to compare three interventions (control, ice, compex) to alleviate the physical symptoms of delayed-onset muscle soreness (DOMS).
Ice application: Participants will apply ice on their hamstring for 15 minutes three times per day until muscle soreness is no longer present</description>
        </group>
        <group group_id="P3">
          <title>Control</title>
          <description>This is a control group where subjects will not perform an intervention.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants first had their leg girth measured with a measuring tape. Pain measurement was taken using a syringe with spring in place of algometer six and 12 inches above the popliteal fossa for tenderness. After completing the visual analog scale, participants completed the induction DOMS protocol.</population>
      <group_list>
        <group group_id="B1">
          <title>'Compex Unit's Active Recovery® Program'</title>
          <description>The Compex electrical stimulation system utilized in this study is intended for external application with electrodes to create a muscular contraction and help enhance recovery after eccentric muscular activity.
Compex unit's Active Recovery® program: Compex unit's Active Recovery® program will be performed for 15 minutes once per day.</description>
        </group>
        <group group_id="B2">
          <title>Ice Application</title>
          <description>A randomized pre and post-test research design will be used to compare three interventions (control, ice, compex) to alleviate the physical symptoms of delayed-onset muscle soreness (DOMS).
Ice application: Participants will apply ice on their hamstring for 15 minutes three times per day until muscle soreness is no longer present</description>
        </group>
        <group group_id="B3">
          <title>Control</title>
          <description>This is a control group where subjects will not perform an intervention.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="25"/>
            <count group_id="B4" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.43" spread="1.25"/>
                    <measurement group_id="B2" value="19.61" spread="1.68"/>
                    <measurement group_id="B3" value="19.78" spread="1.89"/>
                    <measurement group_id="B4" value="19.64" spread="1.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Scores on the Visual Analog Scale</title>
        <description>Visual Analog Scale for Muscle Soreness scale The scale for measuring the intensity of muscle soreness will be a 10 cm visual analog scale, spaced by one centimeter increments from one to 10. Ten will represent the maximum amount of soreness and zero represents no soreness at all. Subjects will be asked to complete this scale once per day at the same time of day until the soreness has dissipated. The Visual Analog Scale for muscle soreness is measured as 'scores on a scale'.</description>
        <time_frame>Day 1 through Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>'Compex Unit's Active Recovery® Program'</title>
            <description>The Compex electrical stimulation system utilized in this study is intended for external application with electrodes to create a muscular contraction and help enhance recovery after eccentric muscular activity.
Compex unit's Active Recovery® program: Compex unit's Active Recovery® program will be performed for 15 minutes once per day.</description>
          </group>
          <group group_id="O2">
            <title>Ice Application</title>
            <description>A randomized pre and post-test research design will be used to compare three interventions (control, ice, compex) to alleviate the physical symptoms of delayed-onset muscle soreness (DOMS).
Ice application: Participants will apply ice on their hamstring for 15 minutes three times per day until muscle soreness is no longer present</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>This is a control group where subjects will not perform an intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Scores on the Visual Analog Scale</title>
          <description>Visual Analog Scale for Muscle Soreness scale The scale for measuring the intensity of muscle soreness will be a 10 cm visual analog scale, spaced by one centimeter increments from one to 10. Ten will represent the maximum amount of soreness and zero represents no soreness at all. Subjects will be asked to complete this scale once per day at the same time of day until the soreness has dissipated. The Visual Analog Scale for muscle soreness is measured as 'scores on a scale'.</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.64" spread="2.21"/>
                    <measurement group_id="O2" value="2.60" spread="2.81"/>
                    <measurement group_id="O3" value="2.45" spread="2.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".80" spread="1.5"/>
                    <measurement group_id="O2" value=".72" spread="1.24"/>
                    <measurement group_id="O3" value=".85" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".4" spread=".82"/>
                    <measurement group_id="O2" value=".56" spread="1.23"/>
                    <measurement group_id="O3" value=".88" spread="1.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".16" spread=".55"/>
                    <measurement group_id="O2" value=".44" spread=".92"/>
                    <measurement group_id="O3" value=".70" spread="1.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".04" spread=".2"/>
                    <measurement group_id="O2" value=".16" spread=".55"/>
                    <measurement group_id="O3" value=".4" spread="1.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>'Compex Unit's Active Recovery® Program'</title>
          <description>The Compex electrical stimulation system utilized in this study is intended for external application with electrodes to create a muscular contraction and help enhance recovery after eccentric muscular activity.
Compex unit's Active Recovery® program: Compex unit's Active Recovery® program will be performed for 15 minutes once per day.</description>
        </group>
        <group group_id="E2">
          <title>Ice Application</title>
          <description>A randomized pre and post-test research design will be used to compare three interventions (control, ice, compex) to alleviate the physical symptoms of delayed-onset muscle soreness (DOMS).
Ice application: Participants will apply ice on their hamstring for 15 minutes three times per day until muscle soreness is no longer present</description>
        </group>
        <group group_id="E3">
          <title>Control</title>
          <description>This is a control group where subjects will not perform an intervention.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tracey Covassin</name_or_title>
      <organization>Michigan State University</organization>
      <phone>517-353-2010</phone>
      <email>covassin@msu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

